Le Lézard
Classified in: Health
Subject: PER

Castle Connolly Private Health Partners, LLC announces the promotion of Dr. Dean McElwain to CEO and Sean Connolly to COO

NEW YORK, Oct. 25, 2020 /PRNewswire/ -- Castle Connolly Private Health Partners, LLC (CCPHP), one of the nation's leaders in the growing field of concierge (membership-model) medicine, has announced the promotion of its President and Chief Operating Officer Dr. Dean McElwain, to Chief Executive Officer. Dr. McElwain is one of the company's founders and has played a key role in the company's development, rapid growth, and success. Dr. John Connolly, the current CEO, will retain the title of Chairman in a non-executive capacity. Mr. Sean Connolly, the company's current Executive Vice President of Strategy and Operations, has been promoted to Chief Operating Officer. These changes will be effective immediately.

McElwain and Connolly bring a depth of executive experience from diverse backgrounds in healthcare, technology, marketing, as well as more than a decade of concierge membership model focused operations and development experience. Dr. McElwain is a seasoned healthcare executive with over 30 years of progressive leadership in a variety of healthcare settings. A recognized national thought leader in the area of concierge medicine, Dr. McElwain has lectured extensively, consulted with leading companies, and provided guidance, leadership, and innovation to hundreds of physicians, as well as regional and national corporate clients, over the last 13 years. Mr. Connolly has deep expertise in marketing and operations, including serving as the CMO for The Trust for Public Land, an environmental non-profit, and leading major sales and marketing initiatives for a range of technology and consumer goods organizations, including Intel, Best Buy, and XM Radio.

"Dean and Sean are the right leaders to continue CCPHP's rapid growth and the company's leadership in the concierge medical field," said Dr. Connolly, CCPHP's Chairman.  "We are fortunate to have someone of Dr. McElwain's caliber and experience to step up and Lead CCPHP."

About Castle Connolly Private Health Partners LLC

Castle Connolly Private Health Partners (CCPHP) works with exceptional physicians to create and support concierge (membership-based) healthcare programs that enable the optimal practice environment and the physician-patient relationship. Members (patients) pay an affordable fee to take advantage of a wide array of enhancements for a more convenient, comprehensive, collaborative, and personalized approach to support health and wellbeing.

Learn more about Castle Connolly Private Health Partners LLC at ccphp.net

Media Contact: Molly Pelosi, Phone: 212-367-1950 ext. 1151, mpelosi@ccphp.net

SOURCE Castle Connolly Private Health Partners, LLC

These press releases may also interest you

at 09:00
? R&D activities focused on advancing the development of innovative delivery systems and yeast beta glucan as a potential inhalable therapeutic for COVID-19 ? ? Q3 2020 sales of $3,476,000 compared to $2,908,000 for Q3 2019, representing a 20%...

at 09:00
The "2020 United States Home Gym Equipment Market" report has been added to ResearchAndMarkets.com's offering. A comprehensive analysis of the United States Home Gym Equipment Market which includes market sizing, market share by competitor, drivers,...

at 09:00
Ziegler, a specialty investment bank, is pleased to announce its role in advising CareFirst BlueCross BlueShield (CareFirst) in the acquisition of University of Maryland Health Partners (UMHP) and University of Maryland Health Advantage (UMHA) from...

at 08:36
Suraksha Naturals has been tapping into a burgeoning aspect of the supplemental health industry with their natural sprayable supplements that are made utilizing Ayurvedic herbs. Suraksha Natural's goal with their Keto-Veyda product line has been to...

at 08:30
The "Global Neurorehabilitation Device Market 2019-2028" report has been added to ResearchAndMarkets.com's offering. The publisher, in its research report, estimates the global neurorehabilitation device market to proliferate with a CAGR of 14.52%...

at 08:05
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announces the filing of a registration statement on Form F-4 (the...

News published on 25 october 2020 at 08:00 and distributed by: